Morgan Stanley lowered the firm’s price target on Ryan Specialty (RYAN) to $65 from $68 and keeps an Overweight rating on the shares. The firm said that, broadly speaking, commercial property and casualty continues to face growth headwinds from the commercial property pricing slowdown in both primary and reinsurance sub-sectors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- 3 Best Stocks to Buy Now, 9/17/2025, According to Top Analysts
- Ryan Specialty upgraded to Overweight from Equal Weight at Wells Fargo
- Wolfe Research launches coverage with positive view on Life Insurance names
- Ryan Specialty assumed with Outperform from Peer Perform at Wolfe Research
- Ryan Specialty Group Appoints Michael Bungert to Board